Breaking News Instant updates and real-time market news.

SNDE

Sundance Energy

$1.09 /

-0.025 (-2.24%)

07:55
10/10/19
10/10
07:55
10/10/19
07:55

Seaport Global cuts Sundance Energy to Neutral among 13 E&P downgrades

As previously reported, Seaport Global analyst Mike Kelly downgraded Sundance Energy to Neutral from Buy. The rating change was among 13 downgrades made in the E&P sector by Kelly, who contends that "the 2020 oil macro set up is a mess." On Sundance specifically, he thinks the stock will have a tough time being assigned a higher valuation given that its balance sheet, returns, and free cash flow all screen in the bottom tier in his ranking.

SNDE Sundance Energy
$1.09 /

-0.025 (-2.24%)

10/10/19 Seaport Global
Sundance Energy downgraded to Neutral from Buy at Seaport Global
07/08/19
SunTrust cuts Pioneer Natural, Oasis Petroleum, Centennial, and Sundance Energy
05/02/19 Imperial Capital
Sundance Energy initiated with an Outperform at Imperial Capital
11/13/18 SunTrust
Sundance Energy initiated with a Buy at SunTrust

TODAY'S FREE FLY STORIES

Downgrade
Tivity Health downgraded to Hold from Buy at Jefferies » 04:53
02/20/20
02/20
04:53
02/20/20
04:53
TVTY

Tivity Health

$22.91 /

+0.06 (+0.26%)

Jefferies analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Analog Devices upgraded to Buy from Neutral at Citi » 04:52
02/20/20
02/20
04:52
02/20/20
04:52
ADI

Analog Devices

$123.83 /

+5.33 (+4.50%)

Citi analyst Christopher…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
AMD downgraded to Equal Weight from Overweight at Wells Fargo » 04:51
02/20/20
02/20
04:51
02/20/20
04:51
AMD

AMD

$58.93 /

+2.04 (+3.59%)

Wells Fargo analyst Aaron…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Community Health upgraded to Market Perform from Underperform at Raymond James » 04:50
02/20/20
02/20
04:50
02/20/20
04:50
CYH

Community Health

$4.80 /

+0.1 (+2.13%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Bloom Energy downgraded to Market Perform from Outperform at Raymond James » 04:50
02/20/20
02/20
04:50
02/20/20
04:50
BE

Bloom Energy

$14.07 /

+2.36 (+20.15%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Ternium upgraded to Overweight from Neutral at JPMorgan » 04:47
02/20/20
02/20
04:47
02/20/20
04:47
TX

Ternium

$20.14 /

-0.38 (-1.85%)

JPMorgan analyst Rodolfo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Fiverr upgraded to Overweight from Neutral at JPMorgan » 04:46
02/20/20
02/20
04:46
02/20/20
04:46
FVRR

Fiverr

/

+

JPMorgan analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
AB InBev downgraded to Underweight from Neutral at JPMorgan » 04:45
02/20/20
02/20
04:45
02/20/20
04:45
BUD

AB InBev

$73.58 /

+0.08 (+0.11%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Black Knight downgraded to Market Perform from Outperform at Keefe Bruyette » 04:44
02/20/20
02/20
04:44
02/20/20
04:44
BKI

Black Knight

$76.08 /

+1.17 (+1.56%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
China Unicom downgraded to Neutral from Buy at Nomura Instinet » 04:42
02/20/20
02/20
04:42
02/20/20
04:42
CHU

China Unicom

$8.73 /

+0.14 (+1.63%)

Nomura Instinet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: USD-CAD has lifted to the mid 1.3200s » 04:00
02/20/20
02/20
04:00
02/20/20
04:00

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: The yen has continued to underperform » 03:30
02/20/20
02/20
03:30
02/20/20
03:30

FX Update: The yen has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The yen has continued to underperform » 03:25
02/20/20
02/20
03:25
02/20/20
03:25

FX Update: The yen has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Ovintiv reports Q4 operating earnings $210M vs. $305M last year » 21:06
02/19/20
02/19
21:06
02/19/20
21:06
OVV

Ovintiv

$16.22 /

+0.865 (+5.63%)

CEO Doug Suttles says:…

CEO Doug Suttles says: "We finished 2019 very strong, marking the second consecutive year of generating free cash flow while growing our crude and condensate production. Our disciplined capital investments, combined with a relentless focus on efficiency and innovation, has transformed Ovintiv into one of the largest independent producers of crude oil and condensate and amongst the top independents in EBITDA generation."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Ovintiv sees FY20 capital investment of $2.7B, down 6% from FY19 » 20:58
02/19/20
02/19
20:58
02/19/20
20:58
OVV

Ovintiv

$16.22 /

+0.865 (+5.63%)

Sees FY20 crude oil and…

Sees FY20 crude oil and condensate volumes growing 4% year-over-year to 229 - 239 Mbbls/d.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
YayYo common stock to be quoted on OTC Pink Market » 20:52
02/19/20
02/19
20:52
02/19/20
20:52
YAYO

YayYo

$0.31 /

-0.0273 (-8.22%)

YayYo has been notified…

YayYo has been notified that its common stock will be quoted on the OTC Pink Market beginning February 20, 2020, following the voluntary delisting of its common stock from the NASDAQ Capital Market. The company will continue trading under the ticker symbol "YAYO."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Endologix price target lowered to $1 from $3 at Piper Sandler » 20:45
02/19/20
02/19
20:45
02/19/20
20:45
ELGX

Endologix

$0.89 /

+0.0547 (+6.51%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien lowered his price target on Endologix to $1 after its in-line Q4 results, saying that while he expects the company's growth profile to improve going forward, its 2019 headwinds around FDA communication and disappointing clinical data will take some some to fix. The analyst adds that he will await the Alto approval before becoming more constructive on Endologix shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Notable companies reporting before tomorrow's open » 20:25
02/19/20
02/19
20:25
02/19/20
20:25
SO

Southern Company

$68.64 /

-0.77 (-1.11%)

, AEP

American Electric

$103.46 /

-0.88 (-0.84%)

, HRL

Hormel Foods

$48.49 /

+0.24 (+0.50%)

, VIAC

ViacomCBS

$35.69 /

+0.59 (+1.68%)

, VIACA

ViacomCBS

$39.57 /

+0.48 (+1.23%)

, TFX

Teleflex

$395.51 /

+7.685 (+1.98%)

, EPAM

Epam Systems

$240.13 /

+2.915 (+1.23%)

, DPZ

Domino's Pizza

$297.46 /

+1.585 (+0.54%)

, NCLH

Norwegian Cruise Line

$52.06 /

+0.38 (+0.74%)

, HSIC

Henry Schein

$73.69 /

+0.7 (+0.96%)

, LKQ

LKQ Corp.

$33.99 /

+0.75 (+2.26%)

, WIX

Wix.com

$155.22 /

+3.47 (+2.29%)

, HFC

HollyFrontier

$42.80 /

+0.3 (+0.71%)

, SIX

Six Flags

$38.01 /

-0.38 (-0.99%)

, COMM

CommScope

$14.50 /

+0.03 (+0.21%)

, AKS

AK Steel

$3.02 /

+0.055 (+1.85%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Southern Company (SO), consensus 27c... American Electric Power (AEP), consensus 58c... Hormel Foods (HRL), consensus 46c... ViacomCBS (VIAC), consensus $1.44... Teleflex (TFX), consensus $3.22... EPAM Systems (EPAM), consensus $1.45... Domino's Pizza (DPZ), consensus $2.98... Norwegian Cruise Line (NCLH), consensus 70c... Henry Schein (HSIC), consensus 91c... LKQ Corp. (LKQ), consensus 52c... Wix.com (WIX), consensus 31c... HollyFrontier (HFC), consensus 52c... Six Flags (SIX), consensus 15c... CommScope (COMM), consensus 34c... AK Steel (AKS), consensus (10c).

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Tocagen, Forte Biosciences to merge » 20:14
02/19/20
02/19
20:14
02/19/20
20:14
TOCA

Tocagen

$0.49 /

-0.0596 (-10.94%)

Tocagen and Forte…

Tocagen and Forte Biosciences, Inc., a privately held clinical-stage biopharmaceutical company developing a live biotherapeutic for the treatment of inflammatory skin diseases, announced that they have entered into a definitive agreement under which Tocagen will merge with Forte in an all-stock transaction. The merged company will focus on advancing Forte's clinical program in inflammatory skin diseases, including atopic dermatitis. Upon stockholder approval, the combined company is expected to operate under the name Forte Biosciences and trade on the Nasdaq Capital Market under the ticker symbol FBRX. Forte's lead asset, FB-401, is a potentially first-in-class, live biotherapeutic being developed as a topical therapy for the treatment of inflammatory skin diseases, including atopic dermatitis. In a Phase 1/2a trial in adults and pediatrics, FB-401 demonstrated significant efficacy and a favorable safety and tolerability profile. The full trial results will be submitted for publication in a peer-reviewed journal in the first half of 2020. A randomized Phase 2 trial is planned to commence in mid-2020 in adults and pediatrics with atopic dermatitis, providing an expected data readout in mid-2021.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Pan American Silver raises quarterly dividend to 5c from 3.5c per share » 20:07
02/19/20
02/19
20:07
02/19/20
20:07
PAAS

Pan American Silver

$24.66 /

+0.71 (+2.96%)

The dividend is payable…

The dividend is payable on or about March 12, 2020, to holders of record of Pan American's common shares as of the close on March 2, 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Pan American Silver reports Q4 silver output 6.6M oz. vs. 6.1M last year » 20:07
02/19/20
02/19
20:07
02/19/20
20:07
PAAS

Pan American Silver

$24.66 /

+0.71 (+2.96%)

Reports Q4 gold output…

Reports Q4 gold output 173.9K oz vs. 37.2K last year.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Pan American Silver sees FY20 silver production up 7%, gold output up 16%  20:06
02/19/20
02/19
20:06
02/19/20
20:06
PAAS

Pan American Silver

$24.66 /

+0.71 (+2.96%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Pan American Silver reports Q EPS 33c, consensus 22c » 20:05
02/19/20
02/19
20:05
02/19/20
20:05
PAAS

Pan American Silver

$24.66 /

+0.71 (+2.96%)

Reports Q revenue…

Reports Q revenue $404.4M, consensus $409.38M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Twist Bioscience 4.64M share Secondary priced at $28.00 » 19:55
02/19/20
02/19
19:55
02/19/20
19:55
TWST

Twist Bioscience

$28.42 /

-2.07 (-6.79%)

The deal size was…

The deal size was increased from $100M to $130M and priced below the last closing price of $28.44. JPMorgan, Cowen and Evercore ISI are acting as joint book running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20
    Feb
Syndicate
Pegasystems prices $525M convertible senior note offering, upsized from $450M » 19:53
02/19/20
02/19
19:53
02/19/20
19:53
PEGA

Pegasystems

$98.36 /

-1.89 (-1.89%)

Pegasystems announced the…

Pegasystems announced the pricing of its offering of $525M aggregate principal amount of 0.75% Convertible Senior Notes due 2025 in a private offering to qualified institutional buyers. The offering size was increased from the previously announced offering size of $450M aggregate principal amount of notes. The offering is expected to close on February 24, 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.